New non-primate draft guidance follows the FDA's wider aim to curtail the use of animal testing in preclinical toxicology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback